Abstract
Duke researchers suggest that small molecule mast cell activators might function as intranasal adjuvants to enhance the typically weak or insufficient immune response to nasal vaccines. However, some researchers raise questions about the potential for unwanted inflammatory effects.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
